April 30th 2024
A study presented at ESCMID examines the efficacy and safety of the vaccine in older populations.
New Vaccine Development Strategy for Leishmaniasis Shows Promise
June 3rd 2016Management of visceral leishmaniasis poses a daunting challenge, in part due to the side effects associated with the use of the traditional treatment. However, one vaccine development strategy has recently shown promising results.
Read More
Influenza Vaccine During Pregnancy May Protect Newborn Infants
May 31st 2016The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.
Read More
Research on Universal Vaccine for Influenza Uncovers More Than Just Financial Limitations
May 2nd 2016A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.
Read More
New Study Finds a Link between a Person's Ethnicity and Response to the Influenza Vaccine
March 1st 2016Researchers from the Dana-Farber Cancer Institute in Boston, MA have, for the first time, identified a link between a person's genetic make-up, as well as their ethnic background, and their response to influenza vaccine.
Read More
The US Department of Health and Human Services (HHS) plans to spend $2.7 billion in emergency funds to counter the spread of Ebola. Spending categories range from over a half billion dollars for international projects to a half million dollars for regulatory work that includes monitoring for fraudulent Ebola products.
Read More